Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Aging Clinical and Experimental Research
|
June 28, 2025
Compared to total serum testosterone, calculated free testosterone has a stronger association with lean mass, muscle strength, power, and physical function in older men
Kristian Villars Lolck, Julian Alcazar, Rikke Stefan Kamper, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 28, 2021
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study
Rikke S Kamper, Julian Alcazar, Lars L Andersen, et al.
Diabetes Care
|
March 29, 2003
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
Peter Hovind, Lise Tarnow, Kasper Rossing, et al.
Diabetes
|
November 30, 2006
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes, Obesity & Metabolism
|
October 19, 2016
The effect of liraglutide on renal function: A randomized clinical trial
Bernt J von Scholten, Frederik Persson, Signe Rosenlund, et al.
Kidney International
|
June 12, 2014
Improved prognosis of diabetic nephropathy in type 1 diabetes
Gudbjörg Andrésdóttir, Majken L Jensen, Bendix Carstensen, et al.
Seminars in Nephrology
|
March 16, 2004
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points
Hans-Henrik Parving, Steen Andersen, Peter Jacobsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Ugeskrift for Laeger
|
January 29, 2005
[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]
Peter Hovind, Lise Tarnow, Peter Rossing, et al.
Diabetes Care
|
December 24, 2005
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy
Tri Q Nguyen, Lise Tarnow, Steen Andersen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Aging Clinical and Experimental Research
|
June 28, 2025
Compared to total serum testosterone, calculated free testosterone has a stronger association with lean mass, muscle strength, power, and physical function in older men
Kristian Villars Lolck, Julian Alcazar, Rikke Stefan Kamper, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
October 28, 2021
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study
Rikke S Kamper, Julian Alcazar, Lars L Andersen, et al.
Diabetes Care
|
March 29, 2003
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
Peter Hovind, Lise Tarnow, Kasper Rossing, et al.
Diabetes
|
November 30, 2006
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Diabetes, Obesity & Metabolism
|
October 19, 2016
The effect of liraglutide on renal function: A randomized clinical trial
Bernt J von Scholten, Frederik Persson, Signe Rosenlund, et al.
Kidney International
|
June 12, 2014
Improved prognosis of diabetic nephropathy in type 1 diabetes
Gudbjörg Andrésdóttir, Majken L Jensen, Bendix Carstensen, et al.
Seminars in Nephrology
|
March 16, 2004
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points
Hans-Henrik Parving, Steen Andersen, Peter Jacobsen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
July 9, 2008
Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study
Frederik Persson, Peter Rossing, Peter Hovind, et al.
Ugeskrift for Laeger
|
January 29, 2005
[Risk factors for the development of microalbuminuria in type 1 diabetes: an incidence cohort study--a secondary publication]
Peter Hovind, Lise Tarnow, Peter Rossing, et al.
Diabetes Care
|
December 24, 2005
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy
Tri Q Nguyen, Lise Tarnow, Steen Andersen, et al.
Page
of 6